FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2026/03/105856 [Registered on: 10/03/2026] Trial Registered Prospectively
Last Modified On: 10/03/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Preventive
Process of Care Changes 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   Effectiveness of Antimicrobial Textiles in Reducing Healthcare-Associated Infections in Post-Operative Liver Transplant ICU: A Quasi-Experimental Study 
Scientific Title of Study   A Single-Site, Parallel-Arm Quasi-Experimental Pilot Study to Evaluate the Effectiveness of Antimicrobial Textiles in Reducing Healthcare-Associated Infections (HAIs) in Post-Operative Liver Transplant ICUs at MGH Hospital, Jaipur 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Prof Naimish N Mehta 
Designation  Professor And Head Department Of HPB Surgery And Liver Transplantation 
Affiliation  Mahatma Gandhi Medical College And Hospital Jaipur 
Address  Centre For Digestive Science Sixth Floor Shri Ram Cancer And Superspeciality Centre, RIICO Institutional Area Sitapura Tonk Road

Jaipur
RAJASTHAN
302022
India 
Phone  9811350626  
Fax    
Email  dr.nmehta@hotmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Prof Naimish N Mehta 
Designation  Professor And Head Department Of HPB Surgery And Liver Transplantation 
Affiliation  Mahatma Gandhi Medical College And Hospital Jaipur 
Address  Centre For Digestive Science Sixth Floor Shri Ram Cancer And Superspeciality Centre, RIICO Institutional Area Sitapura Tonk Road

Jaipur
RAJASTHAN
302022
India 
Phone  9811350626  
Fax    
Email  dr.nmehta@hotmail.com  
 
Details of Contact Person
Public Query
 
Name  Prof Naimish N Mehta 
Designation  Professor And Head Department Of HPB Surgery And Liver Transplantation 
Affiliation  Mahatma Gandhi Medical College And Hospital Jaipur 
Address  Centre For Digestive Science Sixth Floor Shri Ram Cancer And Superspeciality Centre, RIICO Institutional Area Sitapura Tonk Road

Jaipur
RAJASTHAN
302022
India 
Phone  9811350626  
Fax    
Email  dr.nmehta@hotmail.com  
 
Source of Monetary or Material Support  
NIL 
 
Primary Sponsor  
Name  Mahatma Gandhi Medical College And Hospital Jaipur 
Address  RIICO Institutional Area Sitapura Tonk Road Jaipur Rajasthan 302022 India 
Type of Sponsor  Private medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Naimish N Mehta  Mahatma Gandhi Medical College And Hospital  Centre For Digestive Science Shri Ram Cancer And Superspeciality Centre RIICO Institutional Area Sitapura Tonk Road Jaipur Rajasthan 302022 India
Jaipur
RAJASTHAN 
09811350626

dr.nmehta@hotmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee, Mahatma Gandhi Medical College and Hospital, Jaipur  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: Z299||Encounter for prophylactic measures, unspecified,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Antimicrobial Hospital Linen  Hospital Bed Sheets Gowns And Blankets With Embedded Antimicrobial Properties Used In Designated Intensive Care Unit Beds For Post Operative Liver Transplant Patients. The Intervention Will Be Applied Continuously From Intensive Care Unit Admission Until Intensive Care Unit Discharge Or For A Maximum Of Fourteen Days Per Patient. 
Comparator Agent  Standard Hospital Linen  Routine Hospital Bed Sheets Gowns And Blankets Used In Intensive Care Unit Beds As Per Standard Hospital Practice. The Comparator Linen Will Be Used Continuously From Intensive Care Unit Admission Until Intensive Care Unit Discharge Or For A Maximum Of Fourteen Days Per Patient. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  80.00 Year(s)
Gender  Both 
Details  Adult Patients Admitted To Post Operative Liver Transplant Intensive Care Unit
Expected Intensive Care Unit Stay Of At Least Forty Eight Hours
No Evidence Of Healthcare Associated Infection At Time Of Intensive Care Unit Admission
Patients Receiving Routine Post Operative Liver Transplant Care 
 
ExclusionCriteria 
Details  Patients With Documented Healthcare Associated Infection At Time Of Intensive Care Unit Admission
Patients With Expected Intensive Care Unit Stay Less Than Forty Eight Hours
Use Of Non Study Linen During Intensive Care Unit Stay
Patients Enrolled In Another Interventional Infection Prevention Study 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Incidence Of Healthcare Associated Infections Per One Thousand Patient Days In Post Operative Liver Transplant Intensive Care Unit Patients  Baseline At Intensive Care Unit Admission And Daily Assessment Until Intensive Care Unit Discharge Or Up To Fourteen Days After Admission 
 
Secondary Outcome  
Outcome  TimePoints 
Distribution Of Type Specific Healthcare Associated Infections Including Central Line Associated Bloodstream Infection Catheter Associated Urinary Tract Infection Ventilator Associated Pneumonia And Surgical Site Infection  Baseline At Intensive Care Unit Admission And Daily Assessment Until Intensive Care Unit Discharge Or Up To Fourteen Days After Admission 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   21/03/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="10"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Healthcare Associated Infections remain a major cause of morbidity and mortality in post operative liver transplant intensive care units where patients are highly immunocompromised and vulnerable to infections. Environmental reservoirs including hospital linen may contribute to microbial transmission despite routine infection control practices.

This single site parallel arm quasi experimental pilot study aims to evaluate the effectiveness of antimicrobial hospital linen in reducing healthcare associated infections among adult post operative liver transplant patients admitted to the intensive care unit at Mahatma Gandhi Medical College And Hospital Jaipur.

A total of forty eligible patients will be observed across two groups based on fixed intensive care unit bed allocation. One group will receive antimicrobial hospital linen including bed sheets gowns and blankets while the comparator group will receive standard hospital linen used in routine hospital practice. No changes will be made to routine clinical care or infection control protocols.

The primary outcome will be the incidence of healthcare associated infections per one thousand patient days during the intensive care unit stay. Secondary outcomes include distribution of infection types microbial pathogen profile and antimicrobial resistance patterns among confirmed infection cases.

This pilot study will generate real world clinical evidence on the potential role of antimicrobial hospital linen as an environmental infection prevention strategy in high risk transplant intensive care settings in India.

 
Close